Evidence map›Paper›PMID 27298401›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Valproate in Adjuvant Glioblastoma Treatment.

Michael F Fay, Richard Head, Peter Sminia, Nicholas Dowson, Leah Cosgrove, Stephen E Rose, Jenny H Martin

Open access · greenAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Michael F FayUniversity of Newcastle; Genesis Cancer Care; Calvary Mater Hospital; Newcastle, New South Wales; University of Queensland, Brisbane, Queensland, Australia mike.fay@cancer.com.au.
Richard HeadUniversity of South Australia, Adelaide, South Australia, Australia.
Peter SminiaVU University, Amsterdam, the Netherlands.
Nicholas DowsonCSIRO, Brisbane, Queensland, Australia.
Leah CosgroveCSIRO, Adelaide, South Australia, Australia.
Stephen E RoseCSIRO; University of Queensland, Brisbane, Queensland, Australia.
Jenny H MartinUniversity of Newcastle; Calvary Mater Hospital, Newcastle, New South Wales; University of Queensland, Brisbane, Queensland, Australia.
Commonwealth Scientific and Industrial Research Organisation · AUUniversity of Queensland · AUCalvary Mater Newcastle Hospital · AUUniversity of South Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GlioblastomaValproic AcidAntineoplastic Agents, AlkylatingBrain NeoplasmsChemotherapy, AdjuvantCombined Modality TherapyDacarbazineHumansTreatment OutcomeAntineoplastic Agents, AlkylatingDacarbazineValproic Acid

Identifiers

PMID27298401
OpenAlexW2435830227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.